Clinical Benefits Of First-Line (1l) Cemiplimab Monotherapy By Pd-L1 Expression Levels In Patients With Advanced Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
non-small cell lung cancer, anti-PD-1, cemiplimab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要